And I really caution patients and physical therapists that their patients may be checking these things out and they need to understand, A, there's some safety concerns, B, There are sometimes other avenues
Lexapro, with its shorter half-life, often needs a more deliberate taper to avoid an uncomfortable stop-start experience
In order to investigate the tolerability of the treatments, the study participants were additionally dermatologically evaluated after 3, 5, and 7 months
However, the secondary and exploratory endpoints were striking: roughly 18% slower decline on a cognitive composite and close to 50% less loss of grey-matter volume on MRI [10]
That's the rule, and it doesn't change based on payer
PMID 20799803 Quinlan, D